Literature DB >> 16504182

Analysis of the effect of tetrahydrobiopterin on PAH gene expression in hepatoma cells.

Cristina Aguado1, Belén Pérez, Magdalena Ugarte, Lourdes R Desviat.   

Abstract

Tetrahydrobiopterin (BH4)-responsive phenylalanine hydroxylase (PAH) deficiency is a recently recognized variant of phenylketonuria, with a probable multifactorial molecular basis. In this study we have investigated the effect of BH4 on PAH gene expression in human hepatoma. Our results show that increased BH4 levels result in an enhancement of PAH activity and PAH protein, due to longer turnover rates, while PAH mRNA levels remain unchanged. This was confirmed for mutant PAH proteins (A309V, V388M and Y414C) associated to in vivo BH4 responsiveness, validating previous studies. We can conclude that there is no effect of the cofactor on PAH gene transcription, probably being the chemical chaperone effect of BH4 stabilizing mutant PAH proteins the major underlying mechanism of the response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504182     DOI: 10.1016/j.febslet.2006.02.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin.

Authors:  Marte Innselset Flydal; Martín Alcorlo-Pagés; Fredrik Gullaksen Johannessen; Siseth Martínez-Caballero; Lars Skjærven; Rafael Fernandez-Leiro; Aurora Martinez; Juan A Hermoso
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

2.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

Review 3.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

4.  The Missense p.S231F phenylalanine hydroxylase gene mutation causes complete loss of enzymatic activity in vitro.

Authors:  Maja Stojiljkovic; Belén Pérez; Lourdes R Desviat; Cristina Aguado; Magdalena Ugarte; Sonja Pavlovic
Journal:  Protein J       Date:  2009-08       Impact factor: 2.371

Review 5.  Lending a helping hand, screening chemical libraries for compounds that enhance beta-hexosaminidase A activity in GM2 gangliosidosis cells.

Authors:  Michael B Tropak; Don Mahuran
Journal:  FEBS J       Date:  2007-10       Impact factor: 5.542

6.  Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.

Authors:  Angel L Pey; Francois Stricher; Luis Serrano; Aurora Martinez
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

7.  Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients.

Authors:  S F Dobrowolski; A L Pey; R Koch; H Levy; C C Ellingson; E W Naylor; A Martinez
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

Review 8.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

9.  Structural and Functional Impact of Seven Missense Variants of Phenylalanine Hydroxylase.

Authors:  Martina Pecimonova; Daniela Kluckova; Frantisek Csicsay; Kamila Reblova; Jan Krahulec; Dagmar Procházkova; Ludovit Skultety; Ludevit Kadasi; Andrea Soltysova
Journal:  Genes (Basel)       Date:  2019-06-15       Impact factor: 4.096

Review 10.  Sepiapterin reductase: Characteristics and role in diseases.

Authors:  Yao Wu; Peng Chen; Li Sun; Shengtao Yuan; Zujue Cheng; Ligong Lu; Hongzhi Du; Meixiao Zhan
Journal:  J Cell Mol Med       Date:  2020-07-30       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.